Quality of life impairment syndrome in schizophrenia

Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders: New Perspectives on Research and Treatment

Volumn , Issue , 2007, Pages 173-226

  Ritsner, Michael S ^a   Gibel, Anatoly ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Factors; Impairment; Model; Predictors; Quality of life; Schizophrenia

Indexed keywords

EID: 34548115032     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4020-5779-3_10     Document Type: Chapter

References (200)

1. Ritsner M, Kurs R. Impact of antipsychotic agents and their side effects on the quality of life in schizophrenia. Expert Review and Pharmacoeconomic Outcomes Research 2002; 2:89-98.
2. Ritsner M, Kurs R. Quality of life outcomes in mental illness: schizophrenia, mood and anxiety disorders. Expert Review and Pharmacoeconomic Outcomes Research 2003; 3:189-199.
3. Ritsner, M., Kurs, R. Quality-of-Life Impairment in Severe Mental Illness: Focus on Schizoaf-fective Disorders. In: William H. Murray, ed. Schizoaffective Disorder: New Research. NOVA Publishers, NY, 2006, pp. 69-107.
4. Awad AG, Voruganti LN. Impact of atypical antipsychotics on quality of life in patients with schizophrenia. CNS Drugs. 2004, 18:877-893.
5. Lambert M, Naber D. Current issues in schizophrenia: overview of patient acceptability, functioning capacity and quality of life. CNS Drugs. 2004; (18 Suppl) 2:5-17.
6. Hansson L.Determinants of quality of life in people with severe mental illness. Acta Psychiatr Scand 2006; (429 suppl):46-50.
7. Heinrichs DW, Hanlon TE, Carpenter WT. The Quality of Life Scale: an instrument for rating the schizophrenic deficit scale. Schizophrenia Bull. 1984; 10:388-398.
8. Atkinson M, Zibin S, Chuang H. Characterizing quality of life among patients with chronic mental illness: a critical examination of the self-report methodology. Am J Psychiatry 1997; 154:99-105.
9. Voruganti L, Heslegrave R, Awad AG, Seeman MV. Quality of life measurement in schizophrenia: reconciling the quest for subjectivity with the question of reliability. Psychol Med 1998; 28:165-172.
10. Whitty P, Browne S, Clarke M, McTigue O, Waddington J, Kinsella T, Larkin C, O'Callaghan E. Systematic comparison of subjective and objective measures of quality of life at 4-year follow-up subsequent to a first episode of psychosis. J Nerv Ment Dis. 2004; 192:805-809.
11. Ritsner M, Modai I, Endicott J, et al. Differences in quality of life domains and psychopathologic and psychosocial factors in psychiatric patients. J Clin Psychiatry 2000; 61:880-889.
12. Ritsner M, Ponizovsky A, Endicott J, et al. The impact of side-effects of antipsychotic agents on life satisfaction of schizophrenia patients: a naturalistic study. Eur Neuropsychopharmacol 2002; 12:31-38.
13. Ritsner M, Modai I, Kurs R, et al. Subjective Quality of Life Measurements in Severe Mental Health Patients: Measuring Quality of Life of Psychiatric Patients: Comparison Two Questionnaires. Quality Life Research 2002; 11:553-561.
14. Ponizovsky AM, Grinshpoon A, Levav I, Ritsner MS. Life satisfaction and suicidal attempts among persons with schizophrenia. Comprehensive Psychiatry 2003; 44:442-447.
15. Ritsner M, Kurs R, Gibel A, et al. Predictors of quality of life in major psychoses: a naturalistic follow-up study. Journal of Clinical Psychiatry 2003; 64:308-315.
16. Ritsner M, Ben-Avi I, Ponizovsky A, et al. Quality of life and coping with schizophrenia symptoms. Quality of Life Research 2003; 12:1-9.
17. Ritsner M. Predicting changes in domain-specific quality of life of schizophrenia patients. J Nerv Ment Dis 2003; 191:287-294.
18. Ritsner, M., Farkas, H., Gibel, A. Satisfaction with quality of life varies with temperament types of patients with schizophrenia. Journal of Nervous and Mental Disease 2003; 191:668-674.
19. Ritsner M, Kurs R, Ponizovsky A, Hadjez J. Perceived quality of life in schizophrenia: relationships to sleep quality. Quality of Life Research 2004; 13:783-791.
20. Ritsner, M., Perelroyzen, G., Kurs, R., et al. Quality of life outcomes in schizophrenia patients treated with atypical and typical antipsychotic agents: A naturalistic comparative study. International Clinical Psychopharmacology 2004; 24:582-591.
21. Ritsner M, Perelroyzen G, Ilan H, Gibel A. Subjective response to antipsychotics of schizophrenia patients treated in routine clinical practice: a naturalistic comparative study. J Clin Psychophar-macol. 2004; 24:245-54.
22. Ritsner M, Susser E. Temperament types are associated with weak self-construct, elevated distress and emotion-oriented coping in schizophrenia: evidence for a complex vulnerability marker? Psychiatry Res. 2004; 128:219-28.
23. Kurs R, Farkas H, Ritsner M. Quality of life and temperament factors in schizophrenia: comparative study of patients, their siblings and controls. Quality of Life Research 2005; 14:433-440.
24. Ritsner M, Kurs R, Gibel A, Ratner Y, Endicott J. Validity of an abbreviated quality of life enjoyment and satisfaction questionnaire (Q-LES-Q-18) for schizophrenia, schizoaffective, and mood disorder patients. Qual Life Res. 2005; 14:1693-703.
25. Ritsner M, Kurs R, Ratner Y, Gibel A. Condensed version of the Quality of Life Scale for schizophrenia for use in outcome studies. Psychiatry Res. 2005; 135:65-75.
26. Ritsner MS, Ratner Y. The long-term changes in coping strategies in schizophrenia: temporal coping types. J Nerv Ment Dis. 2006; 194:261-267.
27. Ritsner M, Gibel A, Ratner Y. Determinants of Changes in Perceived Quality of Life in the Course of Schizophrenia. Quality of Life Research 2006; 15:515-526.
28. Ritsner MS, Gibel, A. The effectiveness and predictors of response to antipsychotic agents to treat impaired quality of life in schizophrenia: a 12-month naturalistic follow-up study with implications for confounding factors, antidepressants, anxiolytics, and mood stabilizers. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2006;30:1442-1452.
29. Lehman, A. F. The well-being of chronic mental patients: assessing their quality of life. Archives of General Psychiatry 1983; 40:369-373.
30. Sciolla A, Patterson TL, Wetherell JL, et al. Functioning and well-being of middle-aged and older patients with schizophrenia: measurement with the 36-item short-form (SF-36) health survey. Am J Geriatr Psychiatry. 2003; 11:629-637.
31. Gorna K, Jaracz K, Rybakowski F. Objective and subjective quality of life in schizophrenic patients after a first hospitalization. Rocz Akad Med Bialymst. 2005; (50 Suppl) 1:225-7.
32. Law CW, Chen EY, Cheung EF, Chan RC, Wong JG, Lam CL, Leung KF, Lo MS. Impact of untreated psychosis on quality of life in patients with first-episode schizophrenia. Qual Life Res. 2005;14:1803-1811.
33. Kentros MK, Terkelsen K, Hull J, et al.The relationship between personality and quality of life in persons with schizoaffective disorder and schizophrenia. Quality of Life Research, 1997, 6, 118-22.
34. Tollefson GD, Andersen SW. Should we consider mood disturbance in schizophrenia as an important determinant of quality of life? Journal of Clinical Psychiatry 1999; (60 Suppl)5:23-29.
35. Rudolf H, Priebe S. Subjective quality of life in female in-patients with depression: a longitudinal study. International Journal of Social Psychiatry 1999; 45:238-246.
36. Koivumaa-Honkanen HT, Honkanen R, Antikainen R, et al. Self-reported life satisfaction and treatment factors in patients with schizophrenia, major depression and anxiety disorder. Acta Psychiatrica Scandinavica 1999; 99:377-384.
37. Wittchen HU, Carter RM, Pfister H, et al. Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey. Int Clin Psychopharmacol. 2000; 15:319-328.
38. Bystritsky A, Liberman RP, Hwang S, et al. Social functioning and quality of life comparisons between obsessive-compulsive and schizophrenic disorders. Depress Anxiety. 2001; 14:214-218.
39. Bobes J, Gonzalez MP, Bascaran MT, et al. Quality of life and disability in patients with obsessive-compulsive disorder. Eur Psychiatry 2001;16:239-245.
40. Rapaport MH, Clary C, Fayyad R, Endicott J. Quality-of-life impairment in depressive and anxiety disorders. American Journal of Psychiatry 2005; 162:1171-1178.
41. Stone WS, Faraone SV, Seidman LJ, et al. Concurrent validation of schizotaxia: a pilot study. Biol Psychiatry 2001; 50:434-440.
42. Browne S, Clarke M, Gervin M, et al. Determinants of quality of life at first presentation with schizophrenia. Br J Psychiatry 2000; 176:173-176.
43. Melle I, Haahr U, Friis S, et al. Reducing the duration of untreated first-episode psychosis-effects on baseline social functioning and quality of life. Acta Psychiatr Scand. 2005; 112:469-473.
44. Czernikiewicz A, Gorecka J, Kozak-Sykala A. [Premorbid adjustment and quality of life in schizophrenia]. Pol Merkuriusz Lek. 2005; 19:659-662.
45. Erickson DH, Beiser M, Iacono WG, et al. The role of social relationships in the course of first-episode schizophrenia and affective psychosis. Am J Psychiatry. 1989; 146:1456-1461.
46. Bechdolf A, Pukrop R, Kohn D, et al. Subjective quality of life in subjects at risk for a first episode of psychosis: a comparison with first episode schizophrenia patients and healthy controls. Schizophr Res. 2005; 79:137-143.
47. Priebe S, Roeder-Wanner UU, Kaiser W. Quality of life in first-admitted schizophrenia patients: a follow-up study. Psychological Medicine 2000; 30:225-230.
48. Tempier R, Mercier C, Leouffre P, Caron J. Quality of life and social integration of severely mentally ill patients: a longitudinal study. Journal of Psychiatry and Neuroscience 1997; 22:249-255.
49. Skantze K. Subjective quality of life and standard of living: a 10-year follow-up of out-patients with schizophrenia. Acta Psychiatrica Scandinavica 1998; 98:390-399.
50. Hoffmann K, Kaiser W, Isermann M, Priebe S. [How does the quality of life of long-term hospitalized psychiatric patients change after their discharge into the community?] Gesundheitswesen 1998; 60:232-238.
51. Henkel H, Schmitz M, Berghofer G. [Quality of life of the mentally ill] Wiener medizinische Wochenschrift 2000; 150:32-36.
52. Malla AK, Norman RM, McLean TS, McIntosh E. Impact of phase-specific treatment of first episode of psychosis on Wisconsin Quality of Life Index (client version). Acta Psychiatrica Scandinavica 2001;103:355-361.
53. Ruggeri M, Lasalvia A, Tansella M, et al. Heterogeneity of outcomes in schizophrenia. 3-year follow-up of treated prevalent cases. Br J Psychiatry 2004; 184:48-57.
54. Hansson L, Middelboe T, Merinder L, et al. Predictors of subjective quality of life in schizophrenic patients living in the community. A Nordic multicentre study.: International Journal of Social Psychiatry 1999; 45:247-258.
55. Hansson L, Eklund M, Bengtsson-Tops A. The relationship of personality dimensions as measured by the temperament and character inventory and quality of life in individuals with schizophrenia or schizoaffective disorder living in the community. Quality of Life Research 2001; 10:133-139.
56. Eklund M, Backstrom M, Hansson L. Personality and self-variables: important determinants of subjective quality of life in schizophrenia out-patients. Acta Psychiatrica Scandinavica 2003; 108:134-143.
57. Eklund M, Hansson L, Bengtsson-Tops A. The influence of temperament and character on functioning and aspects of psychological health among people with schizophrenia. Eur Psychiatry 2004; 19:34-41.
58. Eklund M, Backstrom M. A model of subjective quality of life for outpatients with schizophrenia and other psychoses. Quality of Life Research 2005; 14:1157-1168.
59. Lazarus, R. S., & Folkman, S. Stress, appraisal, and coping. New York: Springer. 1984.
60. Dohrenwend BP, Shrout PE, Egri G, Mendelsohn FS. Nonspecific psychological distress and other dimensions of psychopathology. Measures for use in the general population. Arch Gen Psychiatry 1980; 37:1229-1236.
61. Derogatis LR, Coons HL. Self-report measures of stress. In: Goldberger L and Breznittz S, ed. Handbook of Stress: Theoretical and Clinical Aspects. Second edition. The Free Press, New York, pp, 200-233 1993; pp, 200-233. 1993.
62. Coyne JC, Schwenk TL. The realtionship of distress to mood disturbance in primary care and psychiatric populations. J Consult Clin Psychol 1997; 65:161-168.
63. Ritsner M, Modai I, Ponizovsky A. The Talbieh Brief Distress Inventory: validation for use with psychiatric patients. Compr Psychiatry 2002; 2:144-163.
64. Norman RMG, Malla AK: Stressful life events and schizophrenia, I: a review of the research. Br J Psychiatry 1993; 162:161-166.
65. Myin-Germeys, I., Jim van, O.S., Schwartz, J.E., Stone, A.A., Delespaul, P.A. Emotional reactivity to daily life stress in psychosis. Archives of General Psychiatry 2001; 58:1093-1208.
66. Ritsner M. The attribution of somatization in schizophrenia patients: a naturalistic follow-up study. J Clin Psychiatry. 2003; 64:1370-8.
67. Selten JP, Wiersma D, van den Bosch RJ. Distress attributed to negative symptoms in schizophrenia. Schizophr Bull 2000; 26:737-744.
68. Fakhoury WK, Wright D, Wallace M. Prevalence and extent of distress of adverse effects of antipsychotics among callers to a United Kingdom National Mental Health Helpline. Int Clin Psychopharmacol 2001; 16:153-1623.
69. Caron J, Lecomte Y, Stip E, Renaud S. Predictors of quality of life in schizophrenia. Community Ment Health J. 2005; 41:399-417.
70. Awad AG, Lapierre YD, Angus C, Rylander A. Quality of life and response of negative symptoms in schizophrenia to haloperidol and the atypical antipsychotic remoxipride. Journal of Psychiatry and Neuroscience 1997; 22:244-248.
71. Lasalvia A, Ruggeri M, Santolini N. Subjective quality of life: its relationship with clinician-rated and patient-rated psychopathology. The South-Verona Outcome Project 6.Psychotherapy and Psychosomatics 2002; 71:275-284.
72. Lobana A, Mattoo SK, Basu D, Gupta N. Quality of life in schizophrenia in India: comparison of three approaches. Acta Psychiatrica Scandinavica 2001; 104:51-55.
73. Hooley JM, Campbell C. Control and controllability: 462 beliefs and behavior in high and low expressed emotion relatives. Psychol Med 2002; 32:1091-1099.
74. Mubarak AR, Barber JG. Emotional expressiveness and the quality of life of patients with schizophrenia. Soc Psychiatry Psychiatr Epidemiol. 2003; 38:380-384.
75. Guillem F, Bicu M, Semkovska, M, Debruille. The dimensional symptom structure of schizophrenia and its association with temperament and character. Schizophrenia Research 2002; 56:137-147.
76. Szoke, A., Schurhoff, F., Ferhadian, N., et al.Temperament in schizophrenia: a study of the tridimensional personality questionnaire (TPQ). European Psychiatry 2002; 17:379-383.
77. Diener E, Diener M. Cross-cultural correlates of life satisfaction and self-esteem. J Pers Soc Psychol. 1995; 68:653-663.
78. Roe D. A prospective study on the relationship between self-esteem and functioning during the first year after being hospitalized for psychosis. J Nerv Ment Dis. 2003; 191:45-9.
79. Gureje O, Harvey C, Herrman H. Self-esteem in patients who have recovered from psychosis: profile and relationship to quality of life. Aust N Z J Psychiatry. 2004; 38:334-338.
80. Zissi A, Barry MM, Cochrane R. A mediational model of quality of life for individuals with severe mental health problems. Psychological Medicine 1998; 28:1221-1230.
81. Ruggeri M, Bisoffi G, Fontecedro L, Warner R. Subjective and objective dimensions of quality of life in psychiatric patients: a factor analytical approach: The South Verona Outcome Project 4. British Journal of Psychiatry 2001; 178:268-275.
82. Jerusalem M, Schwarzer R. Self-efficacy as a resource factor in stress appraisal processes. In R. Schwarzer (Ed.), Self-efficacy: Thought control of action. Hemisphere, Washington, DC pp. 195-213, 1992.
83. Strous, RD, Ratner, Y, Gibel, A, Ponizovsky, A, Ritsner, M. Longitudinal assessment of coping abilities at exacerbation and stabilization in schizophrenia. Comprehensive Psychiatry 2005; 46:167-175.
84. Endler NS, Parker JDA, Summerfeldt LJ. Coping with health problems: Conceptual and methodological issues. Can J Behav Sci 1993; 25:384-399.
85. Lazarus RS. Coping theory and research: past, present, and future. Psychosom Med 55:234-247. 1993.
86. Endler NS, Parker JD. Multidimensional assessment of coping: a critical evaluation. Journal of Personality and Social Psychology 1990; 58:844-854.
87. Wilder-Willis, K.E., Shear, P.K., Steffen, J.J., Borkin, J. The relationship between cognitive dysfunction and coping abilities in schizophrenia. Schizophrenia Research 2002; 55:259-267.
88. Higgins JE, Endler NS. Coping, life stress and psychological and somatic distress. European Journal of Personality 1995; 9:253-270.
89. Lysaker PH, Bryson GJ, Marks K, Greig TC, Bell MD. Coping style in schizophrenia: associations with neurocognitive deficits and personality. Schizophrenia Bulletin 2004; 30:113-121.
90. Bengtsson-Tops A, Hansson L. Quantitative and qualitative aspects of the social network in schizophrenic patients living in the community. Relationship to sociodemographic characteristics and clinical factors and subjective quality of life. International Journal of Social Psychiatry 2001; 47:67-77.
91. Young, K.M. Factors predicting overall life satisfaction for people with long-term mental illness factors. International Journal of Psychosocial Rehabilitation. 2004; 9:23-35.
92. Marshall M, Lewis S, Lockwood A, et al. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry 2005; 62:975-83.
93. Ho BC, Andreasen NC, Flaum M, et al. Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia. Am J Psychiatry 2000; 157:808-815.
94. Harris MG, Henry LP, Harrigan SM, et al. The relationship between duration of untreated psychosis and outcome: an eight-year prospective study. Schizophr Res. 2005; 79:85-93.
95. Malla A, Payne J. First-episode psychosis: psychopathology, quality of life, and functional outcome. Schizophr Bull. 2005; 31:650-671.
96. Sands JR, Harrow M. Depression during the longitudinal course of schizophrenia. Schizophr Bull. 1999; 25:157-71.
97. Packer S, Husted J, Cohen S, Tomlinson G. Psychopathology and quality of life in schizophrenia. Journal of Psychiatry and Neuroscience 1997; 22:231-234.
98. Fitzgerald PB, Williams CL, Corteling N, et al. Subject and observer-rated quality of life in schizophrenia. Acta Psychiatrica Scandinavica 2001;103:387-392.
99. Smith KW, Avis NE, Assmann SF. Distinguishing between quality of life and health status in quality of life research: A meta-analysis. Quality of Life Research: International Journal of Quality of Life Aspects Treatment, Care and Rehabilitation 1999; 8:447-459.
100. Huppert JD, Smith TE. Longitudinal analysis of subjective quality of life in schizophrenia: anxiety as the best symptom predictor. Journal of Nervous and Mental Disease 2001; 189:669-675.
101. Huppert JD, Weiss KA, Lim R, et al. Quality of life in schizophrenia: contributions of anxiety and depression. Schizophrenia Research 2001; 51:171-180.
102. Hofer A, Kemmler G, Eder U, et al. Quality of life in schizophrenia: The impact of psychopathology, attitude toward medication, and side effects. J Clin Psychiatry 2004; 65: 932-939.
103. Braga RJ, Mendlowicz MV, Marrocos RP, Figueira IL.Anxiety disorders in outpatients with schizophrenia: prevalence and impact on the subjective quality of life. J Psychiatr Res. 2005; 39:409-14.
104. Karow A, Moritz S, Lambert M, et al. PANSS syndromes and quality of life in schizophrenia. Psychopathology. 2005; 38:320-326.
105. Huppert JD, Smith TE. Anxiety and schizophrenia: the interaction of subtypes of anxiety and psychotic symptoms. CNS Spectr. 2005;10:721-31.
106. Wetherell JL, Palmer BW, Thorp SR, et al. Anxiety symptoms and quality of life in middle-aged and older outpatients with schizophrenia and schizoaffective disorder. Journal of Clinical Psychiatry 2003; 64:1476-1482.
107. Galletly CA, Clark CR, McFarlane AC, Weber DC. Relationships between changes in symptom ratings, neurophysiological test performance and quality of life in schizophrenic patients treated with clozapine. Psychiatry Res 1997; 72:161-166.
108. Kaiser W, Priebe S, Barr W, et al. Profiles of subjective quality of life in schizophrenic in-and out-patient samples. Psychiatry Research 1997; 66:153-166.
109. Palmer BW, Heaton RK, Paulsen JS, Kuck J, Braff D, Harris MJ, Zisook S, Jeste DV. Is it possible to be schizophrenic yet neuropsychologically normal? Neuropsychology 1997;11:437-446.
110. Heslegrave RJ, Awad AG, Voruganti LN. The influence of neurocognitive deficits and symptoms on quality of life in schizophrenia. J Psychiatry Neurosci 1997; 22:235-243.
111. Dickerson FB, Ringel NB, Parente. Subjective quality of life in out-patients with schizophrenia: clinical and utilization correlates. Acta Psychiatr Scand 1998; 98:124-127.
112. Kaiser W. Cognitive effects of antipsychotics in schizophrenia and relationship to quality of life. British Journal of Psychiatry 2000; 176:92-93.
113. McDermid Vaz SA, Heinrichs RW. Schizophrenia and memory impairment: evidence for a neurocognitive subtype. Psychiatry Research, 2002, 113, 93-105.
114. Sota TL, Heinrichs RW. Demographic, clinical, and neurocognitive predictors of quality of life in schizophrenia patients receiving conventional neuroleptics. Compr Psychiatry. 2004; 45:415-21.
115. Alptekin K, Akvardar Y, Kivircik Akdede BB, et al. Is quality of life associated with cognitive impairment in schizophrenia? Progress in Neuropsychopharmacology and Biological Psychiatry 2005; 29:239-44.
116. Wegener S, Redoblado-Hodge MA, Lucas S, et al. Relative contributions of psychiatric symptoms and neuropsychological functioning to quality of life in first-episode psychosis. Aust N Z J Psychiatry. 2005; 39:487-492.
117. Ritsner, MS. Predicting quality of life impairment in chronic schizophrenia from cognitive variables. Quality of Life Research (2007; in press).
118. Amador, X., Strauss, D., Yale, S., Gorman, J. 1991. Awareness of illness in schizophrenia. Schizophrenia Bulletin 1991; 17:113-132.
119. Browne S, Garavan J, Gervin M, et al. Quality of life in schizophrenia: insight and subjective response to neuroleptics. Journal of Nervous and Mental Disease 1998; 186:74-78.
120. Lysaker PH, Bell MD, Bryson GJ, Kaplan E. Insight and interpersonal function in schizophrenia. Journal of Nervous and Mental Disease 1998; 186:432-436.
121. Zeitlhofer J, Schmeiser-Rieder A, Tribl G, et al. Sleep and quality of life in the Austrian population. Acta Neurologica Scandinavica 2000; 102:249-257.
122. Leger D, Scheuermaier K, Philip P, et al. SF-36: evaluation of quality of life in severe and mild insomniacs compared with good sleepers. Psychosomatic Medicine 2001; 63:49-55.
123. Doi Y, Minowa M, Okawa M, Uchiyama M. Prevalence of sleep disturbance and hypnotic medication use in relation to sociodemographic factors in the general Japanese adult population. Journal of Epidemiology 2000; 10:79-86.
124. Benca, RM. Consequences of insomnia and its therapies. Journal of Clinical Psychiatry 2001; 62 (Suppl 10): S33-S38.
125. Rosch PJ. Stress and sleep: some startling and sobering statistics. Stress Medicine 1996; 12:207-210.
126. Singareddy RK, Balon R. Sleep and suicide in psychiatric patients. Annals of Clinical Psychiatry 2001; 13:93-101.
127. Harris EC, Barraclough B. Suicide as an outcome for mental disorders: a meta-analysis. Br J Psychiatry 1997; 170:205-228.
128. Harkavy-Friedman JM, Resifo K, et al. Suicidal behavior in schizophrenia: characteristics of individuals who had and had not attempted suicide. Am J Psychiatry 1999; 156:1276-1278.
129. Koivumaa-Honkanen HT, Honkanen R, Viinamaki H, et al. Life satisfaction and suicide: a 20-year follow-up study. Am J Psychiatry 2001; 158:433-439.
130. Wiersma D, Nienhuis FJ, Giel R, Slooff CJ. Stability and change in needs of patients with schizophrenic disorders: a 15-and 17-year follow-up from first onset of psychosis, and a comparison between 'objective' and 'subjective' assessments of needs for care. Soc Psychiatry Psychiatr Epidemiol. 1998; 33:49-56.
131. Slade M, Leese M, Ruggeri M, et al. Does meeting needs improve quality of life? Psychother Psychosom. 2004; 73:183-189.
132. Thornicroft G, Tansella M, Becker T, et al. EPSILON Study Group. The personal impact of schizophrenia in Europe. Schizophr Res. 2004; 69:125-132.
133. Korkeila J, Heikkila J, Hansson L, et al. Structure of needs among persons with schizophrenia. Soc Psychiatry Psychiatr Epidemiol. 2005; 40:233-9.
134. Barry MM, Crosby C. Quality of life as an evaluative measure in assessing the impact of community care on people with long-term psychiatric disorders. Br J Psychiatry. 1996; 168:210-6.
135. Brekke JS, Kohrt B, Green MF. Neuropsychological functioning as a moderator of the relationship between psychosocial functioning and the subjective experience of self and life in schizophrenia. Schizophr Bull. 2001; 27:697-708.
136. Becker T, Leese M, Krumm S, et al. EPSILON Study Group.Needs and quality of life among patients with schizophrenia in five European centres: what is the impact of global functioning scores? Soc Psychiatry Psychiatr Epidemiol. 2005; 40:628-634.
137. Priebe S, Warner R, Hubschmid T, Eckle I. Employment, attitudes toward work, and quality of life among people with schizophrenia in three countries. Schizophr Bull 1998; 24:469-77.
138. Eklund M, Hansson L, Bejerholm U. Relationships between satisfaction with occupational factors and health-related variables in schizophrenia outpatients. Soc Psychiatry Psychiatr Epidemiol. 2001; 36:79-83.
139. Bond GR, Resnick SG, Drake RE, et al. Does competitive employment improve nonvocational outcomes for people with severe mental illness? J Consult Clin Psychol. 2001; 69:489-501.
140. Marwaha S, Johnson S. Schizophrenia and employment-a review. Soc Psychiatry Psychiatr Epidemiol. 2004; 39:337-349.
141. Kaiser W, Priebe S, Barr W, et al. Profiles of subjective quality of life in schizophrenic in-and out-patient samples. Psychiatry Research 1997; 66:153-66.
142. Franz M, Meyer T, Reber T, Gallhofer B. The importance of social comparisons for high levels of subjective quality of life in chronic schizophrenic patients. Qual Life Res. 2000; 9:481-9.
143. Hobbs C, Tennant C, Rosen A, et al. Deinstitutionalisation for long-term mental illness: a 2-year clinical evaluation. Aust N Z J Psychiatry. 2000; 34:476-83.
144. Lehman AF, Possidente S, Hawker F. The quality of life of chronic patients in a state hospital and in community residences. Hosp Community Psychiatry 1986; 37:901-7.
145. Kemmler G, Meise U, Tasser A. [Subjective quality of life of schizophrenic patients. Effect of treatment setting, psychopathology and extrapyramidal motor drug effects] Psychiatrische Praxis 1999; 26:9-15.
146. Rossler W, Salize HJ, Cucchiaro G, et al. Does the place of treatment influence the quality of life of schizophrenics? Acta Psychiatr Scand. 1999; 100:142-148.
147. Malla A, Williams R, Kopala L, et al. Outcome on quality of life in a Canadian national sample of patients with schizophrenia and related psychotic disorders. Acta Psychiatr Scand. 2006; 113:22-28.
148. Revicki DA, Genduso LA, Hamilton SH, et al. Olanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders: quality of life and clinical outcomes of a randomized clinical trial. Qual Life Res 1999; 8:417-426.
149. Rovner J, Assuncao S, Gargoloff P, et al.[Functional status and quality of life in Latin American outpatients with schizophrenia treated with atypical or typical antipsychotics: outcomes of the 12 months schizophrenia outpatient health outcomes (IC-SOHO) Study]. Vertex. 2005; 16:332-41 [Article in Spanish].
150. Beasley CM Jr, Sutton VK, Taylor CC, et al. Is quality of life among minimally symptomatic patients with schizophrenia better following withdrawal or continuation of antipsychotic treatment? J Clin Psychopharmacol. 2006; 26:40-44.
151. Mayoral F, Montejo A, Bousono M, et al. Quality of life and social functioning in schizophrenic patients treated with olanzapine: 1 year follow-up naturalistic study. Actas Esp Psiquiatr. 2006; 34:7-15.
152. Rosenheck R, Perlick D, Bingham S, et al. Department of Veterans Affairs Cooperative Study Group on the Cost-Effectiveness of Olanzapine. Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial. JAMA. 2003; 290:2693-702.
153. Strakowski SM, Johnson JL, Delbello MP, et al. Quality of life during treatment with haloperidol or olanzapine in the year following a first psychotic episode. Schizophr Res. 2005; 78:161-169.
154. Gureje O, Miles W, Keks N, et al. Olanzapine vs risperidone in the management of schizophrenia: a randomized double-blind trial in Australia and New Zealand. Schizophr Res 2003; 61:303-314.
155. Ho BC, Nopoulos P, Flaum M, et al. Two-year outcome in first-episode schizophrenia: predictive value of symptoms for quality of life. American Journal of Psychiatry 1998; 155:1196-1201.
156. Werneke U, Turner T, Priebe S. Complementary medicines in psychiatry: review of effectiveness and safety. Br J Psychiatry. 2006; 188:109-21.
157. Aasen I, Kumari V, Sharma T. Effects of rivastigmine on sustained attention in schizophrenia: an FMRI study. J Clin Psychopharmacol. 2005; 25:311-7.
158. Lenzi A, Maltinti E, Poggi E, et al. Effects of rivastigmine on cognitive function and quality of life in patients with schizophrenia. Clin Neuropharmacol. 2003; 26:317-21.
159. Peet M, Stokes C. Omega-3 fatty acids in the treatment of psychiatric disorders. Drugs. 2005; 65:1051-1059.
160. Arvindakshan M, Ghate M, Ranjekar PK, et al. Supplementation with a combination of omega-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia. Schizophr Res. 2003; 62:195-204.
161. Rosenthal MH, Bryant SL. Benefits of adjunct modafinil in an open-label, pilot study in patients with schizophrenia. Clin Neuropharmacol. 2004; 27:38-43.
162. Becker PM, Schwartz JR, Feldman NT, Hughes RJ. Effect of modafinil on fatigue, mood, and health-related quality of life in patients with narcolepsy. Psychopharmacology (Berl). 2004; 171:133-9.
163. Ritsner M, Maayan R, Gibel A, et al. Elevation of the cortisol/dehydroepiandrosterone ratio in schizophrenia patients. European Neuropsychopharmacology 2004; 14:267-273.
164. Ritsner M, Gibel A, Maayan R, et al. Cortisol/dehydroepiandrosterone ratio and responses to antipsychotic treatment in schizophrenia. Neuropsychopharmacology. 2005; 30:1913-22.
165. Ritsner M, Gibel A, Ram E, et al. Alterations in DHEA metabolism in schizophrenia: two-month case-control study. Eur Neuropsychopharmacol. 2006; 16:137-146.
166. Ritsner, MS., Gibel, A., Ratner, Y., et al. Improvement of Sustained Attention, Visual and Movement Skills, but not Clinical Symptomatology, following Dehydroepiandrosterone Augmentation in Schizophrenia: a randomized double-blind, placebo-controlled, crossover trial. Journal of Clinical Psychopharmacology 2006; 26:495-499.
167. Voruganti LN, Heslegrave RJ, Awad AG. Quality of life measurement during antipsychotic drug therapy of schizophrenia. Journal of Psychiatry and Neuroscience 1997; 22:267-274.
168. Dernovsek MZ, Prevolnik Rupel V, Rebolj M, Tavcar R. Quality of life and treatment costs in schizophrenic outpatients, treated with depot neuroleptics. European Psychiatry 2001; 16: 474-482.
169. Browne S, Roe M, Lane A, et al. Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology and tardive dyskinesia. Acta Psychiatr Scand. 1996; 94:118-124.
170. Gerlach J, Larsen EB. Subjective experience and mental side-effects of antipsychotic treatment. Acta Psychiatrica Scandinavica Supplementum 1999; 395:113-117.
171. Allison DB, Mackell JA, McDonnell DD. The impact of weight gain on quality of life among persons with schizophrenia. Psychiatr Serv. 2003; 54:565-567.
172. Olfson M, Uttaro T, Carson WH, Tafesse E. Male sexual dysfunction and quality of life in schizophrenia. J Clin Psychiatry. 2005; 66:331-338.
173. Wirshing DA, Pierre JM, Marder SR, et al. Sexual side effects of novel antipsychotic medications. Schizophr Res. 2002; 56:25-30.
174. Skantze K. Malm U, Dencker S, et al. Comparison of quality of life with standard of living in schizophrenic outpatients. Br J Psychiatry 1992; 161:797-801.
175. Vandiver VL. Quality of life, gender and schizophrenia: a cross-national survey in Canada, Cuba, and U.S.A. Community Ment Health J 1998; 34:501-11.
176. Jarema, M., Konieczynska, Z. Quality of life in schizophrenia: Impact of psychopathology, patients' gender and antipsychotic treatment. Int J Psych Clin Pract 2001; 5:19-26.
177. Patterson TL, Shaw W, Semple SJ, et al. Health-related quality of life in older patients with schizophrenia and other psychoses: relationships among psychosocial and psychiatric factors. Int J Geriatr Psychiatry. 1997; 12:452-461.
178. [No authors listed] Predictors of quality of life in people with severe mental illness. Study methodology with baseline analysis in the UK700 trial. British Journal of Psychiatry, 1999; 175: 426-432.
179. Bechdolf A, Klosterkotter J, Hambrecht M, et al. Determinants of subjective quality of life in post acute patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2003; 253:235.
180. Chan PS, Krupa T, Lawson JS, Eastabrook S. An outcome in need of clarity: building a predictive model of subjective quality of life for persons with severe mental illness living in the community. Am J Occup Ther. 2005; 59:181-190.
181. Ruggeri M, Nose M, Bonetto C, et al. Changes and predictors of change in objective and subjective quality of life: multiwave follow-up study in community psychiatric practice. Br J Psychiatry. 2005; 187:121-130.
182. Gaite L, Vazquez-Barquero JL, Borra C, et al. The EPSILON Study Group. Quality of life in patients with schizophrenia in five European countries: the EPSILON study. Acta Psychiatrica Scandinavica 2002; 105:283-292.
183. Endicott J, Nee J, Harrison W, Blumenthal R. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacology Bulletin 1993; 29:321-326.
184. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC, 1994.
185. Kay, S.R., Fiszbein, A., Opler, L.A., The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987; 13:261-276.
186. White L, Harvey PD, Opler L, Lindenmayer JP. Empirical assessment of the factorial structure of clinical symptoms in schizophrenia. A multisite, multimodel evaluation of the factorial structure of the Positive and Negative Syndrome Scale. The PANSS Study Group. Psychopathology 1997; 30:263-274.
187. Lancon C, Aghababian V, Llorca PM, Auquier P. Factorial structure of the Positive and Negative Syndrome Scale (PANSS): a forced five-dimensional factor analysis. Acta Psychiatrica Scandi-navica 1998; 98:369-376.
188. Lindenmayer JP, Bernstein-Hyman R, Grochowski S. Five-factor model of schizophrenia. Initial validation. Journal of Nervous and Mental Disease 1994; 182:631-638.
189. Mohr PE, Cheng CM, Claxton K, et al. The heterogeneity of schizophrenia in disease states. Schizophrenia Research 2004; 71:83-95.
190. McEvoy JP, Freter S, Everett G, et al. Insight and the clinical outcome of schizophrenic patients. Journal of Nervous and Mental Disease 1989; 177:48-51.
191. Birchwood M, Smith J, Drury V, et al. A Self-Report Insight Scale for Psychosis: Reliability, Validity and Sensitivity to Change. Acta Psychiatrica Scandinavica 1994; 89:62-67.
192. Ritsner M, Rabinowitz J, Slyuzberg M. The Talbieh Brief Distress Inventory: a brief instrument to measure psychological distress among immigrants. Comprehensive Psychiatry 1995; 36:448-453.
193. Ritsner M, Ponizovsky A. Psychological symptoms among immigrant population: a prevalence study. Compr Psychiatry 1998; 39:21-27.
194. Derogatis LR, Spencer PM. The Brief Symptom Inventory (BSI): Administration, Scoring and Procedures Manual. Johns Hopkins University, School of Medicine; 1982.
195. Rosenberg M. Society and the Adolescent Self-image. Princeton, NJ: Princeton University Press; 1965.
196. Zimet GD, Dahlem NW, Zimet SG, Farley GK. The Multidimensional Scale of Perceived Social Support. Journal of Personality Assessment 1988; 52:30-41.
197. Cole JD, Kazarian SS. The level of expressed emotion scale: a new measure of expressed emotion. Journal of Clinical Psychology 1988; 44:392-397.
198. Cole JD, Kazarian SS. Predictive validity of the Level of Expressed Emotion (LEE) Scale: readmission follow-up data for 1, 2, and 5-year periods. J Clin Psychol. 1993; 49:216-8.
199. Cloninger CR A systematic method for clinical description and classification of personality variants. Arch Gen Psychiatry 1987; 44:573-588.
200. Hintze, JL. NCSS 2000 Statistical System for Windows. User's Guide. Number Cruncher Statistical Systems: Kaysville, Utah, 2000.